Cannabidiol for Alcoholism

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
AlcoholismCannabidiol - Drug
Eligibility
21 - 60
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare CBD to a placebo in reducing alcohol consumption for people with moderate alcohol use disorder.

Eligible Conditions
  • Alcoholism

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 4 Secondary · Reporting Duration: 4-8 weeks

0-16 weeks
Anxiety
Subjective Pain Level
0-4 weeks
Sleep Quality
0-8 weeks
Cue-reactivity
4-8 weeks
Alcohol Dependence/Craving
Drinks per Drinking Day

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Side Effects for

Control Group
29%Tiredness
20%Constipation
18%Drowsiness
11%Dizziness
11%Poor sleep
9%Poor Appetite
9%Headache
4%Itching
4%Nausea
2%Diarrhea
This histogram enumerates side effects from a completed 2022 Phase 2 & 3 trial (NCT04387617) in the Control Group ARM group. Side effects include: Tiredness with 29%, Constipation with 20%, Drowsiness with 18%, Dizziness with 11%, Poor sleep with 11%.

Trial Design

3 Treatment Groups

Full-spectrum Cannabidiol
1 of 3
Broad-spectrum Cannabidiol
1 of 3
Placebo
1 of 3

Active Control

Experimental Treatment

Non-Treatment Group

45 Total Participants · 3 Treatment Groups

Primary Treatment: Cannabidiol · Has Placebo Group · Phase 2

Broad-spectrum Cannabidiol
Drug
Experimental Group · 1 Intervention: Cannabidiol · Intervention Types: Drug
Full-spectrum Cannabidiol
Drug
ActiveComparator Group · 1 Intervention: Cannabidiol · Intervention Types: Drug
Placebo
Drug
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cannabidiol
FDA approved

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 4-8 weeks

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,594 Previous Clinical Trials
1,927,351 Total Patients Enrolled
11 Trials studying Alcoholism
2,227 Patients Enrolled for Alcoholism

Eligibility Criteria

Age 21 - 60 · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a current AUD of at least moderate severity.
You have at least one heavy drinking day (4 or more drinks per day for women/5 or more drinks per day for men) during the 7-day period prior to screening.
You are between 21 and 60 years old.
You have a minimum alcohol intake of at least 21 standard alcoholic drinks per week.
You live within 35 miles of the study site.\n